Erudio Healtherudio.com
Sponsor
Shanghai Junshi Bioscience trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Shanghai Junshi Bioscience yet. Erudio has found public clinician commentary on 4 clinical trials sponsored by Shanghai Junshi Bioscience: JUPITER-02, Neotorch, RENOTORCH and TORCHLIGHT. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Shanghai Junshi Bioscience Co., Ltd.). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| Neotorch NCT04158440 · Shanghai Junshi Bioscience Co., Ltd. DeepView → | resectable stage II-III non-small cell lung cancer | Phase 3 | Deep | View | |||
| RENOTORCH NCT04394975 · Shanghai Junshi Bioscience Co., Ltd. DeepView → | first-line unresectable or metastatic renal cell carcinoma | Phase 3 | Deep | View | |||
| JUPITER-02 NCT03581786 · Shanghai Junshi Bioscience Co., Ltd. DeepView → | recurrent or metastatic nasopharyngeal carcinoma | Phase 3 | Deep | View | |||
| TORCHLIGHT NCT04085276 · Shanghai Junshi Bioscience Co., Ltd. FocusedView → | metastatic or recurrent triple-negative breast cancer | Phase 3 | Focused | View | |||